Stock data
Integra LifeSciences Holdings Corporation (IART)
Integra LifeSciences Holdings Corporation (IART) reported revenue of US$1.64B and net income of -US$516.47M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.64B | — | -US$493.37M | -US$516.47M | — |
| 2024 | US$1.61B | — | US$28.41M | -US$6.94M | — |
| 2023 | US$1.54B | — | US$111.53M | US$67.74M | — |
| 2022 | US$1.56B | — | US$238.92M | US$180.55M | — |
| 2021 | US$1.54B | — | US$197.23M | US$169.07M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$418.76M | US$4.48M | — |
| 2026-03-31 | US$391.92M | -US$4.62M | — |
| 2025-12-31 | US$434.93M | -US$1.70M | — |
| 2025-09-30 | US$402.06M | -US$5.40M | — |
| 2025-06-30 | US$415.61M | -US$484.07M | — |
| 2025-03-31 | US$382.65M | -US$25.29M | — |
| 2024-12-31 | US$442.65M | US$19.43M | — |
| 2024-09-30 | US$380.83M | -US$10.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.